NSC |
Compound |
Enrichment |
Correlation |
NSC 683416 |
1H-Pyrrole-2-carboxamide, N-[2-[[[4-[[5,5a,6,8,8a,9-hexahydro- 5-(4-hydroxy-3,5-dimethoxyphenyl)- 6-oxofuro[3',4':6,7]naphtho[1,2-d]-1,3-dioxol-9-yl]amino] phenyl]amino]carbonyl]-1-methyl-1H-pyrrol-4 |
0.0480633950058471 |
0.071364599 |
NSC 699767 |
Null |
0.0480633950058471 |
0.019026342 |
NSC 708419 |
Null |
0.0480633950058471 |
0.017088423 |
NSC 720326 |
2-(5,6,7-Trimethoxyindol-2-carbonyl)amino-4H-pyrazolo[1,5-a] indole |
0.0480633950058471 |
-0.10365292 |
NSC 733164 |
Null |
0.0480633950058471 |
-0.14931271 |
NSC 742838 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride |
0.0480633950058471 |
0.12868599 |
NSC 744020 |
methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate |
0.0480633950058471 |
-0.042615049 |
NSC 751644 |
Null |
0.0480633950058471 |
0.040194197 |
NSC 757981 |
Null |
0.0480633950058471 |
0.023482334 |
NSC 758965 |
CEPHARANTHINE |
0.0480633950058471 |
0.13688063 |